HealthDay News — Telemedicine adoption is associated with modestly lower use of low-value, point-of-care testing among Medicare beneficiaries, according to a study published online Feb. 24 in JAMA ...

The approval was based on a comprehensive clinical data package, which included a single phase 1 trial and a phase 3 trial.

While this pembrolizumab-based regimen is promising and much needed in this patient population, one should remain cognizant of its high costs and the subsequent impact this may have on patients and ...

A multivariate analysis confirmed the independent prognostic significance of both landmark and longitudinal MRD.

This systematic review sought the effects of communication interventions that combine patient- and clinical-targeted interventions on patient-clinician discussions and patient outcomes.

Increased mixed chimerism, as detected by AlloHeme, could predict post-transplant relapse “with a high degree of accuracy,” said Monzr M. Al Malki, MD.

Results of a pilot study showed a support program for caregivers and patients coping with surgery for early-stage lung cancer was feasible and accepted, but other outcomes were inconclusive.

In recent study, PAC-MANN identified pancreatic ductal adenocarcinoma samples with 98 percent specificity and 73 percent sensitivity across all stages.

Anemia and low performance status predict worse survival and greater risk for treatment failure in low-intermediate risk vs ...

Oncology nurses play essential roles in the emerging field of cardio-oncology, which aims to protect patients’ heart function ...

GEMSTONE-303 is the first trial demonstrating a statistically significant survival benefit for addition of an anti-PD-L1 antibody to standard chemotherapy for advanced gastric and gastroesophageal ...

Updated results from the TALAPRO-2 trial “support talazoparib plus enzalutamide as a standard-of-care initial treatment option for patients with mCRPC,” according to Neeraj Agarwal, MD.